| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2004;110:16-21.)
© 2004 American Heart Association, Inc.
Original Articles |
From the MRC Clinical Trials Unit (A.R.B.), London, UK; the MRC Biostatistics Unit (S.G.T.), Cambridge, UK; the Wolfson Unit for Prevention of Peripheral Vascular Diseases (F.G.R.F.), Public Health Sciences, Edinburgh University Medical School, Edinburgh, UK; and the Department of Vascular Surgery (R.M.G., J.T.P.), Imperial College at Charing Cross Hospital, London, UK.
Correspondence to Prof Janet Powell, Department of Vascular Surgery, Imperial College at Charing Cross Hospital, Fulham Palace Rd, London W6 8RF, UK. E-mail j.powell{at}imperial.ac.uk
Received December 8, 2003; de novo received January 26, 2004; accepted March 19, 2004.
Background Intervention to reduce abdominal aortic aneurysm (AAA) expansion and optimization of screening intervals would improve current surveillance programs. The aim of this study was to characterize AAA growth in a national cohort of patients with AAA both overall and by cardiovascular risk factors.
Methods and Results In this study, 1743 patients were monitored for changes in AAA diameter by ultrasonography over a mean follow-up of 1.9 years. Mean initial AAA diameter and growth rate were 43 mm (range 28 to 85 mm) and 2.6 mm/year (95% range, 1.0 to 6.1 mm/year), respectively. Baseline diameter was strongly associated with growth, suggesting that AAA growth accelerates as the aneurysm enlarges. AAA growth rate was lower in those with low ankle/brachial pressure index and diabetes but higher for current smokers (all P<0.001). No other factor (including lipids and blood pressure) was associated with AAA growth. Intervals of 36, 24, 12, and 3 months for aneurysms of 35, 40, 45, and 50 mm, respectively, would restrict the probability of breaching the 55-mm limit at rescreening to below 1%.
Conclusions Annual, or less frequent, surveillance intervals are safe for all AAAs
45 mm in diameter. Smoking increases AAA growth, but atherosclerosis plays a minor role.
Key Words: aneurysm aorta atherosclerosis smoking
This article has been cited by other articles:
![]() |
J. Golledge, P. S. Tsao, R. L. Dalman, and P. E. Norman Circulating Markers of Abdominal Aortic Aneurysm Presence and Progression Circulation, December 2, 2008; 118(23): 2382 - 2392. [Full Text] [PDF] |
||||
![]() |
T. Tsuruda, J. Kato, K. Hatakeyama, K. Kojima, M. Yano, Y. Yano, K. Nakamura, F. Nakamura-Uchiyama, Y. Matsushima, T. Imamura, et al. Adventitial Mast Cells Contribute to Pathogenesis in the Progression of Abdominal Aortic Aneurysm Circ. Res., June 6, 2008; 102(11): 1368 - 1377. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. T. Baxter, M. C. Terrin, and R. L. Dalman Medical Management of Small Abdominal Aortic Aneurysms Circulation, April 8, 2008; 117(14): 1883 - 1889. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Golledge, M. Karan, C. S. Moran, J. Muller, P. Clancy, A. E. Dear, and P. E. Norman Reduced expansion rate of abdominal aortic aneurysms in patients with diabetes may be related to aberrant monocyte-matrix interactions Eur. Heart J., March 1, 2008; 29(5): 665 - 672. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Freiberg, A. M. Arnold, A. B. Newman, M. S. Edwards, K. L. Kraemer, and L. H. Kuller Abdominal Aortic Aneurysms, Increasing Infrarenal Aortic Diameter, and Risk of Total Mortality and Incident Cardiovascular Disease Events: 10-Year Follow-Up Data From the Cardiovascular Health Study Circulation, February 26, 2008; 117(8): 1010 - 1017. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mory, J. Hansmann, J.-R. Allenberg, and D. Boeckler Images in vascular medicine: Rapid expansion of an inflammatory abdominal aortic aneurysm Vascular Medicine, November 1, 2007; 12(4): 381 - 382. [PDF] |
||||
![]() |
P.E. Norman and J.T. Powell Abdominal Aortic Aneurysm: The Prognosis in Women Is Worse Than in Men Circulation, June 5, 2007; 115(22): 2865 - 2869. [Full Text] [PDF] |
||||
![]() |
J. M. Gitlin, D. B. Trivedi, R. Langenbach, and C. D. Loftin Genetic deficiency of cyclooxygenase-2 attenuates abdominal aortic aneurysm formation in mice Cardiovasc Res, January 1, 2007; 73(1): 227 - 236. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Golledge, J. Muller, A. Daugherty, and P. Norman Abdominal Aortic Aneurysm: Pathogenesis and Implications for Management Arterioscler. Thromb. Vasc. Biol., December 1, 2006; 26(12): 2605 - 2613. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Shimizu, R. N. Mitchell, and P. Libby Inflammation and Cellular Immune Responses in Abdominal Aortic Aneurysms Arterioscler. Thromb. Vasc. Biol., May 1, 2006; 26(5): 987 - 994. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. L. King, D. B. Trivedi, J. M. Gitlin, and C. D. Loftin Selective Cyclooxygenase-2 Inhibition With Celecoxib Decreases Angiotensin II-Induced Abdominal Aortic Aneurysm Formation in Mice Arterioscler. Thromb. Vasc. Biol., May 1, 2006; 26(5): 1137 - 1143. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Touat, V. Ollivier, J. Dai, M.-G. Huisse, A. Bezeaud, U. Sebbag, T. Palombi, P. Rossignol, O. Meilhac, M.-C. Guillin, et al. Renewal of Mural Thrombus Releases Plasma Markers and Is Involved in Aortic Abdominal Aneurysm Evolution Am. J. Pathol., March 1, 2006; 168(3): 1022 - 1030. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Erbel and H. Eggebrecht Aortic dimensions and the risk of dissection Heart, January 1, 2006; 92(1): 137 - 142. [Full Text] [PDF] |
||||
![]() |
C. Longo and G. R. Upchurch Jr Abdominal Aortic Aneurysm Screening: Recommendations and Controversies Vascular and Endovascular Surgery, May 1, 2005; 39(3): 213 - 219. [Abstract] [PDF] |
||||
![]() |
E. M. Isselbacher Thoracic and Abdominal Aortic Aneurysms Circulation, February 15, 2005; 111(6): 816 - 828. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |